XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Investments (Details) - Schedule of statements of operation - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
BioFirst [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales $ 23,079 $ 17,451
Gross profit 5,747 5,414
Net loss (993,643) (887,230)
Share of losses from investments accounted for using the equity method (193,147)
Rgene [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales
Gross profit
Net loss (450,995) (411,897)
Share of losses from investments accounted for using the equity method